MedPath

Stugeron

Brand Name: Stugeron

Generic Name: Cinnarizine

Active
Registration Number

DR-XY34825

Dosage Form

Tablet

Issuance Date

July 8, 2023

Expiry Date

August 20, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25 mg
PackagingAlu/PVC Blister Pack x 20's (Box of 200's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-vertigo
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CinnarizineActive
Monograph: Cinnarizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform